Clinical trial
PTC124 for the Treatment of Cystic Fibrosis
NCT00351078 · PTC Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00351078 |
|---|---|
| Title | PTC124 for the Treatment of Cystic Fibrosis |
| Official title | A Phase 2b Extension Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis |
| Lead sponsor | PTC Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | PTC124 |
| Enrollment | 19 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jul 12, 2006 |
| Last update posted | Dec 13, 2017 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: